Prime Medicine, Inc. (PRME)
3.99
+0.41
(+11.45%)
USD |
NASDAQ |
Oct 09, 16:00
3.99
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Free Cash Flow : -156.85M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -156.85M |
| March 31, 2026 | -158.74M |
| December 31, 2025 | -167.10M |
| September 30, 2025 | -115.10M |
| June 30, 2025 | -107.00M |
| March 31, 2025 | -111.41M |
| December 31, 2024 | -130.16M |
| September 30, 2024 | -190.32M |
| June 30, 2024 | -205.20M |
| March 31, 2024 | -200.61M |
| Date | Value |
|---|---|
| December 31, 2023 | -174.14M |
| September 30, 2023 | -163.96M |
| June 30, 2023 | -156.77M |
| March 31, 2023 | -139.00M |
| December 31, 2022 | -147.92M |
| September 30, 2022 | -125.96M |
| June 30, 2022 | -102.50M |
| March 31, 2022 | -84.82M |
| December 31, 2021 | -38.23M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Beam Therapeutics, Inc. | -372.77M |
| Twist Bioscience Corp. | -93.22M |
| Intellia Therapeutics, Inc. | -348.69M |
| Moderna, Inc. | -1.244B |
| Q32 Bio, Inc. | -19.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.05M |
| Cash from Investing (Quarterly) | 24.03M |
| Cash from Financing (Quarterly) | 0.361M |
| Free Cash Flow Per Share (Quarterly) | -0.2319 |
| Free Cash Flow to Equity (Quarterly) | -39.06M |
| Free Cash Flow to Firm (Quarterly) | -41.09M |
| Free Cash Flow Yield | -22.61% |